Parvalbumin interneurons dysfunction is potentially associated with FαMNs decrease and NRG1-ErbB4 signaling...

Area of Science:

• Neuroscience
• Neurodegenerative Diseases
• Cellular Biology

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
• Alterations in interneuron populations and signaling pathways are implicated in ALS pathogenesis.
• The role of parvalbumin (PV) interneurons and ErbB4 signaling in ALS progression remains incompletely understood.

Purpose of the Study:

• To investigate dynamic changes in PV interneurons in an ALS mouse model.
• To explore the relationship between PV interneurons, motor neurons, and ErbB4 signaling in ALS.
• To assess the therapeutic potential of NRG1 on these markers.

Main Methods:

• Utilized SOD1G93A mice as a model for ALS.
• Analyzed animals at different disease stages: symptomatic prophase, phase, and progression.
• Employed immunofluorescence, RT-qPCR, and western blot to quantify PV, MMP-9, ChAT, NeuN, and ErbB4 expression.

Main Results:

• PV expression was higher in the anterior horn of control mice.
• In ALS mice, PV, MMP-9, and ErbB4 levels progressively decreased with disease onset and progression.
• Significant downregulation of PV, MMP-9, and ErbB4 was observed in ALS mice post-onset, correlating with FαMNs decline. NRG1 treatment increased these markers.

Conclusions:

• The study demonstrates a concurrent decrease in PV interneurons, FαMNs, and ErbB4 in ALS mice.
• These findings highlight the intricate relationship between interneuron dysfunction and motor neuron degeneration in ALS.
• NRG1 emerges as a potential therapeutic agent for restoring key molecular markers in ALS.